Cancer researcher (IMAGE)

Virginia Tech

Cancer researcher

Caption

In an invited review article this week in Cancer Discovery, a journal of the American Association for Cancer Research, Kathleen Mulvaney, a Virginia Tech assistant professor with the Fralin Biomedical Research Institute at VTC, talks about the potential of a new drug that has shown early promise in clinical trials for solid tumors by killing cancer cells with that lack specific genes. 

Credit

Virginia Tech

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.